3rd Annual Mintz/ML Strategies Pharmacy & Pharmaceutical Industry Summit

Topics

• The Evolving Drug Supply Chain - Disruptor Models and the Amazon Effect
• Addressing Drug Pricing and Supply Chain Economics – Government Initiatives and ERISA Litigation
• Government Enforcement Targeting Financial Relationships
• The Uncertain State of 340B
• Combating the Opioid Crisis
• Addressing Drug Pricing and Supply Chain Economics – Government Initiatives and ERISA Litigation
• Addressing Drug Pricing and Supply Chain Economics – Government Initiatives and ERISA Litigation
• The Uncertain State of 340B

Our 3rd Annual Pharmacy & Pharmaceutical Industry Summit will bring together stakeholders and thought leaders from across the industry to discuss legal and policy challenges facing manufacturers, PBMs, payors, pharmacies, hospitals, and other providers.

Among other topics, we will provide an update on developments to state and federal laws including changes in the Medicare Part D Program, and delve into issues that are impacting the industry — and your business. We will explore cutting-edge topics such as developments in the 340B program, how the industry is addressing the opioid crisis, and innovative service models — including the Amazon effect, and the continued debate over drug prices.